Facebook
Twitter
LinkedIn
Forward2023 Cancer Immunotherapy Summit: Everything, Everywhere, All At Once
This CME-accredited conference, "2023 Cancer Immunotherapy Summit: Everything, Everywhere, All At Once," features leading experts in the field who will provide a comprehensive overview of current and emerging strategies to integrate immunotherapy in the management of cancers. These experts will offer their insights on mechanisms of immunotherapy toxicity, host factors regulating efficacy and resistance, and neoadjuvant immunotherapy, all in the pursuit of improving patient outcomes. This activity aims to enhance learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to incorporate immunotherapy and optimize clinical outcomes for cancer patients. The oncology conference will use a mix of didactic lectures and case-based panel discussions to highlight areas of debate in the field of immuno-oncology. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to contribute effectively to patient care.
Target Audience
Medical oncologists
Hematologist oncologists
Oncology/Hematology residents/fellows
Oncology NPs/PAs
Oncology pharmacists
Oncology nurses
Learning Objectives
- Review mechanisms of action of currently approved and emerging immunotherapies
- Review indications and outcomes of approved immunotherapies.
- Identify and manage complications of immunotherapies.
- State the financial, physical, and other barriers, and review strategies to navigate these factors to optimize the management of patients with immunotherapies.
- Discuss novel neoadjuvant and adoptive therapies in the management of cancers.
- Incorporate biomarkers in the management plan of cancers.
Conference Chair: Dr. Shailender Bhatia
DAY 1 - September 22, 2023
All times below are listed in Pacific Standard Time (PST).
03:00PM – 06:00 PM: SESSION I: IMMUNOTHERAPY MODALITIES: MECHANISMS OF ACTION
Moderator: TBD
03:00 PM - 03:15 PM: Welcome, introductions and pre-tests -
03:15 PM - 03:40 PM: Immuno-checkpoint inhibitors: old and new -
03:40 PM - 04:05 PM: Adoptive T cell therapy: what is on the horizon? -
04:05 PM - 04:30 PM: T-cell antagonists and bispecific T-cell engagers
04:30 PM - 04:55 PM: Harnessing innate immunity (NK cells, TLRs, MDSCs etc..)
04:55 PM - 05:00 PM: Post-test
05:00 PM - 06:00 PM: Panel discussion: financial toxicity
DAY 2 - September 23, 2023
08:00 AM - 10:00 AM: SESSION I: IMMUNOTHERAPY MODALITIES: MECHANISMS OF ACTION
Moderator: TBD
08:00 AM - 08:10 AM: Welcome and pre-test
08:10 AM - 08:35 AM: Skin cancers (melanoma and non-melanoma skin cancers)
08:35 AM - 09:00 AM: Lung cancer
09:00 AM - 09:25 AM: Women's cancers (breast, gynecologic malignancies)
09:25 AM - 09:30 AM: Post-test
09:30 AM - 10:00 AM: Panel discussion: duration of therapy
10:00 AM - 10:30 AM: BREAK AND NETWORKING
10:30 AM - 12:00 PM: SESSION III: IMMUNOTHERAPY BIOMARKERS
Moderator:
10:30 AM - 10:35 AM: Pre-test
10:35 AM - 11:00 AM: PD-L1
11:00 AM - 11:25 AM: TILs
11:25 AM - 11:50 AM: TMB
11:50 AM - 12:00 PM: Post-test
12:00 PM - 01:00 PM: LUNCH AND NETWORKING
01:00 PM - 01:45 PM: Keynote lecture - Cancer vaccines: the future is bright
01:45 PM - 03:15 PM: SESSION IV: UPDATES IN CANCER IMMUNOTHERAPY (PART 2)
01:45 PM - 01:50 PM: Pre-test
01:50 PM - 02:10 PM: Urotherial cancer
02:10 PM - 02:30 PM: Multiple Myeloma
02:30 PM - 02:50 PM: Renal cell carcinoma
02:50 PM - 02:55 PM: Post-test
02:55 PM - 03:15 PM: Panel discussion: Access to cellular therapy in academia and community
03:15 PM - 03.30: BREAK
03:30 PM - 05:30 PM: IMMUNE-RELATED ADVERSE EVENTS
03:30 PM - 03:35 PM: Pre-test
03:35 PM - 03:55 PM: Colitis
03:55 PM - 04:15 PM: Rheumatologic toxicities
04:15 PM - 04:35 PM: Myocarditis
04:35 PM - 04:55 PM: Dermatologic toxicities
04:55 PM - 05:00 PM: Post-test
05:00 PM - 05:30 PM: Panel discussion: Use of ICIs in pre-existing autoimmunity/organ transplant/prior IRAEs
The Coeur d'Alene Resort
FACULTY INFORMATION COMING SOON
Binay Shah, MD, MHA
Binay Shah, MD, MHA
Available Credit
- 10.75 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 10.75 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 10.75 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.75 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
- No refunds will be issued if registration is cancelled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.